Sumitomo Mitsui DS Asset Management Company Ltd Has $18.64 Million Stake in Danaher Co. (NYSE:DHR)

Sumitomo Mitsui DS Asset Management Company Ltd raised its position in Danaher Co. (NYSE:DHR) by 3.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 81,180 shares of the conglomerate’s stock after purchasing an additional 2,890 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Danaher were worth $18,635,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. AMF Tjanstepension AB bought a new stake in Danaher during the 3rd quarter valued at $5,923,000. Miracle Mile Advisors LLC bought a new stake in Danaher during the 3rd quarter valued at $310,000. Brookstone Capital Management increased its stake in Danaher by 7.0% during the 3rd quarter. Brookstone Capital Management now owns 11,048 shares of the conglomerate’s stock valued at $3,071,000 after purchasing an additional 720 shares in the last quarter. First PREMIER Bank grew its stake in shares of Danaher by 750.0% in the 3rd quarter. First PREMIER Bank now owns 340 shares of the conglomerate’s stock worth $95,000 after acquiring an additional 300 shares in the last quarter. Finally, CWM LLC grew its stake in shares of Danaher by 0.5% in the 3rd quarter. CWM LLC now owns 23,159 shares of the conglomerate’s stock worth $6,439,000 after acquiring an additional 125 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 1.0 %

Shares of Danaher stock opened at $209.95 on Friday. Danaher Co. has a 12-month low of $209.10 and a 12-month high of $281.70. The company has a market cap of $151.64 billion, a price-to-earnings ratio of 39.76, a PEG ratio of 2.80 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company’s 50-day moving average price is $233.96 and its 200-day moving average price is $252.39.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the business earned $2.09 EPS. On average, equities analysts expect that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DHR. TD Cowen upped their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. KeyCorp upped their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 10.90% of the stock is owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.